Balanced news tone
News Sentiment
ILA sentiment intelligence
Island Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
92/100 classification confidence.
directly relevant articles
high-authority source matches
+20.0% over one week, +18.4% over four weeks, trend inactive, and materially above fair value.
Island Pharmaceuticals Signs Statement of Work With Texas Biomed to Advance Galidesivir, Shares Hit Six Month High
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Island Pharmaceuticals Signs Statement of Work With Texas Biomed to Advance Galidesivir, Shares Hit Six Month High
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 14:28
- Source
- Moomoo
Why Did Island Pharmaceuticals Ltd (ASX: ILA) Jump 14.44%?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 06:32
- Source
- Kalkine
Insider Sales At Island Pharmaceuticals Landed A Good Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 20:53
- Source
- simplywall.st
Island Pharmaceuticals (ASX: ILA) Eases 10.5% After a Strong Year
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jul 2026 03:40
- Source
- Kalkine
Why Island Pharmaceuticals (ASX:ILA) Shares Are Trading Higher On Tuesday?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Kalkine
Island Pharmaceuticals (ASX:ILA) gets Uganda green light to treat live Ebola outbreak with Galidesivir
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Stocks Down Under
Has Island Pharmaceuticals (ASX:ILA) More Growth Ahead After a 164% One-Year Rally?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Kalkine
Island Pharmaceuticals Halts Trading Pending Further Company Update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Kalkine
Island Pharmaceuticals (ASX:ILA) Falls as Investors Reassess Clinical-Stage Biotech Risks
- Tone
- Negative 18/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Kalkine
Island Pharmaceuticals (ASX:ILA) Advances IP Strategy with Singapore Patent
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Kalkine
Island Pharmaceuticals Says Singapore Granted Patent for Antiviral Therapy; Shares Jump 4%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Moomoo
Island Pharmaceuticals (ASX:ILA) Drops as Biotech Traders Turn Cautious
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Kalkine
Island Pharmaceuticals (ASX:ILA) Advances Galidesivir Program with New FDA Recognition
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Kalkine
Island Pharmaceuticals (ASX:ILA) Gains as Galidesivir Development Reaches New Stage
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Kalkine
Island Pharmaceuticals (ASX:ILA) Advances Biodefence Push with Strategic Appointment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Kalkine
When Can We Expect A Profit From Island Pharmaceuticals Limited (ASX:ILA)?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 19 May 2026 07:00
- Source
- simplywall.st
Island Pharmaceuticals (ASX:ILA): Ebola outbreak puts antiviral stocks in focusIsland Pharmaceuticals (ASX:ILA): Ebola outbreak puts antiviral stocks in focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Kalkine
Inside Biotech: Island Pharmaceuticals pushes deeper into US biodefence as Ebola fears spark interest
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Proactive financial news
Health Check: Island Pharmaceuticals shares soar on spreading Ebola outbreak
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Stockhead
Island Pharmaceuticals (ASX:ILA) Surges—Phase 2 Data Changes Everything?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- Kalkine
Loss-Making Island Pharmaceuticals Limited (ASX:ILA) Expected To Breakeven In The Medium-Term
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2026 08:00
- Source
- Market source
Insights: Island Pharmaceuticals Ltd (ASX:ILA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Oct 2025 14:14
- Source
- smallcaps.com.au
We're Hopeful That Island Pharmaceuticals (ASX:ILA) Will Use Its Cash Wisely
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 28 Oct 2025 07:00
- Source
- simplywall.st
Analysts Expect Breakeven For Botanix Pharmaceuticals Limited (ASX:BOT) Before Long
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Oct 2025 07:00
- Source
- Market source
Island Pharmaceuticals Ltd Company Profile & Introduction
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Sep 2024 07:00
- Source
- Moomoo